The Gordon Research Conference on Fragile X and neurodevelopmental conditions,  will be held in conjunction with the “Fragile X and Autism-Related Disorders” Gordon Research Seminar. You can view more details on the conference here. Chaired by Sebastien Jaquemont and David Nelson, and vice-chaired by FraXI Advisors Claudia Bagni and Peng Jin, the Gordon Research Conference on Fragile X this June unites like-minded researchers in the field of FXS and related conditions. 

The event is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritising time for discussion after each talk and fostering informal interactions among scientists of all career stages. 

The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. FraXI’s President Kirsten Johnson will be leading a discussion under the theme “Methodologies in Clinical Trials and N of One, N of Few”. This is the first time FraXI has attended the Gordon’s Research Conference on FXS and thanks the organisers for welcoming our participation. This is a real opportunity to elevate the voice of lived experience in regard to clinical trial design and development, and to share our lived reality with scientists and researchers.